D-0044-2025 Class II Ongoing
FDA drug recall D-0044-2025 was initiated by Cipla USA, Inc. on Oct 23, 2024 and is designated Class II. Reason for recall: Failed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets. The recall status is ongoing. Affected quantity: N/A.
Recall Details
- Product Type
- Drugs
- Report Date
- Nov 20, 2024
- Initiation Date
- Oct 23, 2024
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- N/A
Product Description
Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for Exelan Pharmaceuticals, NDC 76282-0478-90
Reason for Recall
Failed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets.
Distribution Pattern
USA nationwide.
Code Information
Lot# NB240873, Exp 03/31/2026